CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
September 23, 2020
VIA EDGAR SUBMISSION
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS
CytoDyn Inc.
Registration Statement on Form S-3
File No. 333-248823
Ladies and Gentlemen:
CytoDyn Inc. (the Company) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the Registration Statement) so that the Registration Statement will become effective at 4:30 p.m. (Eastern time) on Friday, September 25, 2020, or as soon thereafter as practicable.
The Company requests the Commission confirm the effective date and time of the Registration Statement to Arian Colchis, General Counsel of the Company, by telephone at (360) 998-3992.
Very truly yours,
CytoDyn Inc. |
/s/ Michael D. Mulholland |
Michael D. Mulholland |
Chief Financial Officer |
cc: Kara Tatman (Perkins Coie LLP)